PDCD1 and neoplasm: Remarkably, the authors noted that anti-PD1 therapy addition to the DMPtNPS@cGAMP and radiotherapy combination resulted in sustained complete responses for 60 days in 100% of primary tumors and in 50% of distant tumors in a bilateral tumor mouse model.